Long-Term Efficacy Study of Vatiquinone for the Treatment of Friedreich’s Ataxia (PROVE-FA)
|Jun 25 2026
Effects of Aerobic Training on Friedreich’s Ataxia
|Oct 30 2024
A Study to Learn More About the Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich’s Ataxia Who Are Prescribed it by Their Own Doctors
|Oct 29 2024
SKYCLARYS (Omaveloxolone) Pregnancy and Lactation Surveillance Program
|Apr 4 2024
Vatiquinone (PTC-743)
|Mar 19 2024
A Study to Learn More About the Effects and Long-Term Safety of BIIB141 (Omaveloxolone) in Participants with Friedreich’s Ataxia Aged 2 to 15 Years Old (BRAVE)
|Mar 19 2024
NAD+ and Exercise in FA (ExRx in FA) – Nicotinamide Riboside (NR)
|Mar 19 2024
Omaveloxolone Dose Finding Study in Children With Friedreich’s Ataxia (BOLD)
|Mar 19 2024
A Study to Assess the Safety and Efficacy of Vatiquinone in Participants With Friedreich Ataxia
|Mar 19 2024
A Randomized, Parallel-Arm, Double-Blind, Placebo-Controlled Study With Open-Label Extension to Assess the Efficacy and Safety of Vatiquinone for the Treatment of Friedreich Ataxia (MOVE-FA)
|Mar 19 2024
A Study of Vatiquinone for the Treatment of Participants with Friedreich’s Ataxia